Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 575

Results For "ED"

9539 News Found

BioPhy launches AI platform to accelerate the drug development market
Digitisation | November 14, 2023

BioPhy launches AI platform to accelerate the drug development market

The company has raised US$4.5 million in funding for its AI operating system


Bayer and Recursion focus research collaboration on Oncology
Digitisation | November 14, 2023

Bayer and Recursion focus research collaboration on Oncology

Digitally enabled drug discovery for oncology with potential to accelerate the delivery of new cancer therapies to patients


Narayana Hrudayalaya Q2 FY PAT up at Rs. 226.58 Cr
News | November 14, 2023

Narayana Hrudayalaya Q2 FY PAT up at Rs. 226.58 Cr

Narayana Hrudayalaya has reported total income of Rs. 1323.64 crores during the period ended September 30, 2023


Vaishali Pharma posts Q2 FY24 PAT at Rs. 1.70 Cr
News | November 13, 2023

Vaishali Pharma posts Q2 FY24 PAT at Rs. 1.70 Cr

he company posted total income during Q2 FY24 at Rs. 12.86 crore


Sun Pharma joins hands with WOTR to create water harvesting capacity in Maharashtra
News | November 13, 2023

Sun Pharma joins hands with WOTR to create water harvesting capacity in Maharashtra

This collaboration underscores WOTR's unwavering commitment to strengthening rural communities against the unpredictable variations of climate change


Granules India Q2 FY24 PAT drops 30% at Rs. 102 Cr
News | November 13, 2023

Granules India Q2 FY24 PAT drops 30% at Rs. 102 Cr

Sales in the US region grew well, partially offset by the decline in the LATAM and European regions


Glenmark Pharma reports Q2 FY24 loss at Rs. 62 Cr
News | November 13, 2023

Glenmark Pharma reports Q2 FY24 loss at Rs. 62 Cr

European operations' revenue grew 58.4% to Rs 599.7 crore


GSK registers 5% revenue growth in Q2 FY24
News | November 10, 2023

GSK registers 5% revenue growth in Q2 FY24

General Medicine grows 5% and Vaccines 10% led by Shingrix


Aurobindo Pharma posts Q2 FY 24 up 84% at Rs. 752 Cr
News | November 10, 2023

Aurobindo Pharma posts Q2 FY 24 up 84% at Rs. 752 Cr

The company reported net profit after share of profit/loss of JV and minority interest at Rs. 752 crore vs. Rs. 409 crore in Q2FY23


SMS Pharmaceuticals reports robust Q2FY24 operational performance
News | November 10, 2023

SMS Pharmaceuticals reports robust Q2FY24 operational performance

Q2FY24 EBITDA up by 105% y-o-y at Rs. 28 crore